OVA Peptide 257-264 2TFA 1262751-08-5(TFA-2TFA)
CAS No. ——
OVA Peptide 257-264 2TFA 1262751-08-5(TFA-2TFA)( —— )
Catalog No. M22904 CAS No. ——
OVA Peptide 257-264 2TFA is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H-2Kb.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 400 | In Stock |
|
| 10MG | 668 | In Stock |
|
| 25MG | 1019 | In Stock |
|
| 50MG | 1560 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOVA Peptide 257-264 2TFA 1262751-08-5(TFA-2TFA)
-
NoteResearch use only, not for human use.
-
Brief DescriptionOVA Peptide 257-264 2TFA is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H-2Kb.
-
DescriptionOVA Peptide 257-264 2TFA is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H-2Kb.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight1191.17
-
Molecular FormulaC49H76F6N10O17
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC[C@H](N)C(N[C@H](C(N[C@H](C(N[C@@H](CC(N)=O)C(N[C@H](C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(O)=O)=O)=O)=O)CC1=CC=CC=C1)=O)=O)[C@@H](C)CC)=O)[C@@H](C)CC)=O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Dehydroandrographoli...
Dehydroandrographolide Succinate is a traditional Chinese medicine used in the treatment of pneumonia, respiratory tract infection.
-
Bifendatatum
Bifendatatum is commonly used to treat the transaminase elevation that caused by viral hepatitis and drug induced liver injury.
-
Remimazolam
Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?
Cart
sales@molnova.com